MedPage Today on MSN
Personalized DNA Vaccine Shows Promise in Brain Cancer
Survival rate surpasses historical outcomes in a small phase I study ...
A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.
Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...
A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...
All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer ...
Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...
Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new ...
Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren’t recorded in the same way everywhere in Europe. A new ...
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...
Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results